Copyright Reports & Markets. All rights reserved.

Global Stem Cell Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Stem Cell Drugs Market Overview

  • 1.1 Product Overview and Scope of Stem Cell Drugs
  • 1.2 Stem Cell Drugs Segment by Type
    • 1.2.1 Global Stem Cell Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Cord Blood-Derived
    • 1.2.3 Adipose-Derived
    • 1.2.4 Bone Marrow-Derived
    • 1.2.5 Others
  • 1.3 Stem Cell Drugs Segment by Application
    • 1.3.1 Stem Cell Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Acute Graft-versus-Host Disease
    • 1.3.3 Crohn’s Disease
    • 1.3.4 Amyotrophic Lateral Sclerosis
    • 1.3.5 Osteoarthritis
    • 1.3.6 Others
  • 1.4 Global Stem Cell Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Stem Cell Drugs Revenue 2016-2027
    • 1.4.2 Global Stem Cell Drugs Sales 2016-2027
    • 1.4.3 Stem Cell Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Stem Cell Drugs Market Competition by Manufacturers

  • 2.1 Global Stem Cell Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Stem Cell Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Stem Cell Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Stem Cell Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Stem Cell Drugs Market Competitive Situation and Trends
    • 2.5.1 Stem Cell Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Stem Cell Drugs Players Market Share by Revenue
    • 2.5.3 Global Stem Cell Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Stem Cell Drugs Retrospective Market Scenario by Region

  • 3.1 Global Stem Cell Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Stem Cell Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Stem Cell Drugs Market Facts & Figures by Country
    • 3.3.1 North America Stem Cell Drugs Sales by Country
    • 3.3.2 North America Stem Cell Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Stem Cell Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Stem Cell Drugs Sales by Country
    • 3.4.2 Europe Stem Cell Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Stem Cell Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Stem Cell Drugs Sales by Region
    • 3.5.2 Asia Pacific Stem Cell Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Stem Cell Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Stem Cell Drugs Sales by Country
    • 3.6.2 Latin America Stem Cell Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Stem Cell Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Stem Cell Drugs Sales by Country
    • 3.7.2 Middle East and Africa Stem Cell Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Stem Cell Drugs Historic Market Analysis by Type

  • 4.1 Global Stem Cell Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Stem Cell Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Stem Cell Drugs Price by Type (2016-2021)

5 Global Stem Cell Drugs Historic Market Analysis by Application

  • 5.1 Global Stem Cell Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Stem Cell Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Stem Cell Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 JCR Pharmaceuticals Co., Ltd
    • 6.1.1 JCR Pharmaceuticals Co., Ltd Corporation Information
    • 6.1.2 JCR Pharmaceuticals Co., Ltd Description and Business Overview
    • 6.1.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 JCR Pharmaceuticals Co., Ltd Product Portfolio
    • 6.1.5 JCR Pharmaceuticals Co., Ltd Recent Developments/Updates
  • 6.2 CORESTEM, Inc
    • 6.2.1 CORESTEM, Inc Corporation Information
    • 6.2.2 CORESTEM, Inc Description and Business Overview
    • 6.2.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 CORESTEM, Inc Product Portfolio
    • 6.2.5 CORESTEM, Inc Recent Developments/Updates
  • 6.3 Pharmicell Co., Ltd
    • 6.3.1 Pharmicell Co., Ltd Corporation Information
    • 6.3.2 Pharmicell Co., Ltd Description and Business Overview
    • 6.3.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pharmicell Co., Ltd Product Portfolio
    • 6.3.5 Pharmicell Co., Ltd Recent Developments/Updates
  • 6.4 Anterogen
    • 6.4.1 Anterogen Corporation Information
    • 6.4.2 Anterogen Description and Business Overview
    • 6.4.3 Anterogen Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Anterogen Product Portfolio
    • 6.4.5 Anterogen Recent Developments/Updates
  • 6.5 Chiesi Pharmaceuticals
    • 6.5.1 Chiesi Pharmaceuticals Corporation Information
    • 6.5.2 Chiesi Pharmaceuticals Description and Business Overview
    • 6.5.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Chiesi Pharmaceuticals Product Portfolio
    • 6.5.5 Chiesi Pharmaceuticals Recent Developments/Updates
  • 6.6 Takeda
    • 6.6.1 Takeda Corporation Information
    • 6.6.2 Takeda Description and Business Overview
    • 6.6.3 Takeda Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Takeda Product Portfolio
    • 6.6.5 Takeda Recent Developments/Updates
  • 6.7 New York Blood Center
    • 6.6.1 New York Blood Center Corporation Information
    • 6.6.2 New York Blood Center Description and Business Overview
    • 6.6.3 New York Blood Center Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 New York Blood Center Product Portfolio
    • 6.7.5 New York Blood Center Recent Developments/Updates
  • 6.8 MEDIPOST
    • 6.8.1 MEDIPOST Corporation Information
    • 6.8.2 MEDIPOST Description and Business Overview
    • 6.8.3 MEDIPOST Stem Cell Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 MEDIPOST Product Portfolio
    • 6.8.5 MEDIPOST Recent Developments/Updates

7 Stem Cell Drugs Manufacturing Cost Analysis

  • 7.1 Stem Cell Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Stem Cell Drugs
  • 7.4 Stem Cell Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Stem Cell Drugs Distributors List
  • 8.3 Stem Cell Drugs Customers

9 Stem Cell Drugs Market Dynamics

  • 9.1 Stem Cell Drugs Industry Trends
  • 9.2 Stem Cell Drugs Growth Drivers
  • 9.3 Stem Cell Drugs Market Challenges
  • 9.4 Stem Cell Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Stem Cell Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Stem Cell Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Stem Cell Drugs by Type (2022-2027)
  • 10.2 Stem Cell Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Stem Cell Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Stem Cell Drugs by Application (2022-2027)
  • 10.3 Stem Cell Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Stem Cell Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Stem Cell Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Cord Blood-Derived
    Adipose-Derived
    Bone Marrow-Derived
    Others

    Segment by Application
    Acute Graft-versus-Host Disease
    Crohn’s Disease
    Amyotrophic Lateral Sclerosis
    Osteoarthritis
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    JCR Pharmaceuticals Co., Ltd
    CORESTEM, Inc
    Pharmicell Co., Ltd
    Anterogen
    Chiesi Pharmaceuticals
    Takeda
    New York Blood Center
    MEDIPOST

    Buy now